These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1002001)

  • 1. Pretreatment with heparin in thrombolytic therapy with Urokinase. Heparin-urokinase therapy.
    Bizzi B; Leone G; Accorrà F
    Haemostasis; 1976; 5(3):147-54. PubMed ID: 1002001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modifications in coagulation parameters induced by treatment associating urokinase (2000 u CTA/kg/h) with heparin.
    Juhan I; Calas MF; Buonocore M; Mathieu P; Isnard G; Cazenave B; Serradimigni A
    Thromb Haemost; 1979 Oct; 42(3):945-54. PubMed ID: 315625
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes in coagulation and fibrinolytic factors observed during heparin-urokinase-pulse combined therapy for nephritis resistant to conventional treatment in children].
    Koitabashi Y; Ikoma M; Shibawaka T; Yamaguchi Y; Mio H; Doi K; Meguro T; Yamada K
    Nihon Jinzo Gakkai Shi; 1993 Oct; 35(10):1155-61. PubMed ID: 7505345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thrombolytic therapy with urokinase. Clinical trials].
    Bizzi B; Leone G; Tutinelli F; Landolfi R
    Clin Ter; 1978 Sep; 86(5):419-32. PubMed ID: 737966
    [No Abstract]   [Full Text] [Related]  

  • 5. Some aspects of the dose-response relation in urokinase administration.
    Matsuo O; Rokushima Y
    Thromb Res; 1976 May; 8(2 suppl):97-106. PubMed ID: 936100
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasminogen and moderate doses of urokinase in the treatment of acute pulmonary embolism.
    Griguer P; Charbonnier B; Latour F; Fauchier JP; Brochier M
    Angiology; 1979 Jan; 30(1):1-12. PubMed ID: 426316
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombolytic treatment of venous thromboembolism.
    Gurewich V
    Vasc Surg; 1977; 11(6):341-2. PubMed ID: 616147
    [No Abstract]   [Full Text] [Related]  

  • 8. [Studies on blood coagulation and fibrinolytic activities in the three cases of cerebral infarction treated with urokinase. 1st report--120,000 I.U. administrated-- (author's transl)].
    Fujita S; Itoga T; Shou T; Yamamoto H; Ishikawa H
    Rinsho Ketsueki; 1978 Jun; 19(6):850-8. PubMed ID: 713046
    [No Abstract]   [Full Text] [Related]  

  • 9. [Thrombolytic therapy using urokinase in cerebral thrombosis (author's transl)].
    Sakuragawa N
    Nihon Naika Gakkai Zasshi; 1979 May; 68(5):486-9. PubMed ID: 469353
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of alpha 2-plasmin inhibitor in the appearance of fibrinolytic activity during urokinase administration, and an evaluation of the optimal urokinase dosage.
    Hayashi S; Yamada K
    Thromb Res; 1979; 16(3-4):393-400. PubMed ID: 92817
    [No Abstract]   [Full Text] [Related]  

  • 11. A pilot study of urokinase therapy in cerebral infarction.
    Fletcher AP; Alkjaersig N; Lewis M; Tulevski V; Davies A; Brooks JE; Hardin WB; Landau WM; Raichle ME
    Stroke; 1976; 7(2):135-42. PubMed ID: 1265805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thrombolytic therapy for pulmonary thromboembolism].
    Pankov KS
    Klin Med (Mosk); 2004; 82(10):4-8. PubMed ID: 15584590
    [No Abstract]   [Full Text] [Related]  

  • 13. [Thrombolytic agents and acute pulmonary emboli. Study of 28 cases treated by streptokinase or urokinase-heparin].
    Chiche P; Bénaim R; Samama M; Maury J
    Coeur Med Interne; 1978; 17(1):59-66. PubMed ID: 639489
    [No Abstract]   [Full Text] [Related]  

  • 14. An evaluation of fibrinolytic therapy of pulmonary thromboembolism using non-invasive examinations and the relationship of urokinase dosage to clinical outcome and coagulation-fibrinolytic changes.
    Oguma Y; Hasegawa H; Kawakami Y
    Jpn Circ J; 1988 Feb; 52(2):131-8. PubMed ID: 3361699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinolysis--a perspective.
    Kwaan HC
    Prog Cardiovasc Dis; 1979; 21(5):397-403. PubMed ID: 154125
    [No Abstract]   [Full Text] [Related]  

  • 16. Blood coagulation changes during effective thrombolysis using urokinase and heparin.
    Schöffel G; Zimmermann R; Harenberg J; Mörl H
    Thromb Res; 1982 Jan 1-15; 25(1-2):11-21. PubMed ID: 6175040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fibrinolytic therapy of deep venous thrombosis. Streptokinase, urokinase, plasminogen substitution].
    Theiss W; Kriessmann A; Wirtzfeld A
    Dtsch Med Wochenschr; 1980 Feb; 105(8):243-6. PubMed ID: 6986252
    [No Abstract]   [Full Text] [Related]  

  • 18. [Evidence-based guidelines for prevention and therapy of venous thromboembolism].
    Falciani M; Dilaghi B; Conti AA; Caciolli S; Gensini GF
    Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):27-35. PubMed ID: 11253337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-urokinase treatment in aseptic dural sinus thrombosis.
    Di Rocco C; Iannelli A; Leone G; Moschini M; Valori VM
    Arch Neurol; 1981 Jul; 38(7):431-5. PubMed ID: 7018470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined use of heparin and urokinase in the patients with nephritis resistant to the conventional treatment and the significance of alpha 2-plasmin inhibitor in the therapy (author's transl)].
    Koitabashi Y; Maruyama T; Ikoma M; Miyaji Y; Yamada K; Shimizu K
    Rinsho Ketsueki; 1982 Mar; 23(3):309-18. PubMed ID: 7050462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.